DUBLIN--(BUSINESS WIRE)--The "Leukapheresis - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.
The Leukapheresis market worldwide is projected to grow by US$12.1 Million, driven by a compounded growth of 7.1%.
Leukapheresis Devices, one of the segments analyzed and sized in this study, displays the potential to grow at over 7.3%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$14.4 Million by the year 2025, Leukapheresis Devices will bring in healthy gains adding significant momentum to global growth.
Representing the developed world, the United States will maintain a 8.1% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$557.4 Thousand to the region's size and clout in the next 5 to 6 years. Over US$566.1 Thousand worth of projected demand in the region will come from the rest of the European markets.
In Japan, Leukapheresis Devices will reach a market size of US$1.2 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 6.8% over the next couple of years and add approximately US$2.1 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.
Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific.
All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.
Competitors identified in this market include:
- Allcells LLC
- Asahi Kasei Medical Co. Ltd.
- BioIVT
- Caltag Medsystems Limited
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- HemaCare Corporation
- Key Biologics, LLC
- MacoPharma S.A.
- Ppa Research Group, Inc.
- Precision Medicine Group, Inc.
- StemCell Technologies Inc.
- StemExpress
- Terumo BCT, Inc.
- Zenbio, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/54dsa0
